The Asia Pacific closed systems drug transfer devices market is expected to reach US$ 345.83 million by 2027 from US$ 75.23 million in 2019; it is estimated to grow at a CAGR of 21.1% from 2019 to 2027.
Driving factors include growing adoption of chemotherapy and closed system drug transfer devices. However, the lack of regulatory guidelines regarding health workers’ safety in emerging countries may restrain the market growth.The closed system drug transfer devices provide protection against hazardous drugs or vapors during drug preparation and administration. It comprises components which enables filtering of dangerous vapors out of the system. Closed system drug transfer devices play a major role in protection of healthcare professionals from antineoplastic as well as other harmful medications. Growing emphasis on implementation of occupational health and safety standards by government authorities are offering lucrative opportunity for growth of the market.
Several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics, are used during patient treatment protocols. Pharmacists, physicians, nurses, and other healthcare workers are at significant risk of exposure to hazardous drugs. Cancer is the leading cause of death in China. The cancer treatment comprises the utilization of antineoplastic drugs that can cause several health implications if ingested. The antineoplastic can have a severe impact during pregnancies, and the exposure can lead to chromosomal abnormalities. The surface contamination of chemotherapy treatment can impact healthcare professionals and the patient and their families. An increasing number of cancer cases are anticipated to drive the adoption of chemotherapies. According to the Globocan Cancer Statistics 2018, an estimated 4.3 million new cancer cases and 2.9 million new cancer deaths occurred in China in 2018. China is undergoing the cancer transition stage where the cancer spectrum is changing, with a rapid increase in cancer burden of colorectal, prostate, and female breast cancers and a high occurrence of infection-related and digestive cancers. Thus, the consequent surge in adopting chemotherapies would eventually drive the demand for closed systems drug transfer devices in the coming years.
A few studies have proven the effectiveness of closed-system drug transfer devices to prevent surface contamination in oncology settings. These devices prohibit the escape of harmful drug or vapor concentrations outside the system; they also prevent environmental contaminants' entry into the system. Many government organizations recommend using closed-system drug transfer devices to avoid any exposure to potentially hazardous drugs. Such effectiveness of closed-system drug transfer devices, coupled with the growing adoption of chemotherapies, drives the growth of the closed system drug transfer device market.
Considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19. With its aging population having chronic diseases and the growing burden of cancer, Asia is facing the dual challenge of controlling the spread of COVID-19 and at the same time providing and maintaining cancer care. There is also the potential for negative impacts of both a medium- and longer-term nature on R&D and manufacturing activities, and delay on projects. These factors are affecting the growth of the Closed System Drug Transfer Device (CSTD) market in the region.
Rest of Asia Pacific Closed Systems Drug Transfer Devices Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC CLOSED SYSTEMS DRUG TRANSFER DEVICES MARKET SEGMENTATION
By Closing Mechanism
- Push-to-turn Systems
- Luer-lock Systems
- Color-to-color Alignment Systems
- Click-to-lock Systems
By Type
- Membrane-to-membrane Systems
- Needleless Systems
By Technology
- Diaphragm-based Devices
- Compartmentalized Devices
- Air Cleaning/Filtration Devices
By Component
- Vial Access Devices
- Syringe Safety Devices
- Bag/Line Access Devices
- Accessories
By End User
- Hospitals and Clinics
- Oncology Centers
- Others
By Country
- China
- Japan
- India
- South Korea
- Australia
Company Profiles
- JMS CO., LTD
- Caragen Ltd.
- BD
- B. Braun Medical Inc
- ICU MEDICAL INC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Closing Mechanism, Type, Technology, Component, and End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Closed system drug transfer devices Market – By Closing Mechanism
1.3.2 Asia Pacific Closed system drug transfer devices Market – By Type
1.3.3 Asia Pacific Closed system drug transfer devices Market– By Technology
1.3.4 Asia Pacific Closed system drug transfer devices Market– By Component
1.3.5 Asia Pacific Closed system drug transfer devices Market– By End User
1.3.6 Asia Pacific Closed system drug transfer devices Market – By Country
2. Asia Pacific Closed System Drug Transfer Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Closed System Drug Transfer Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Closed System Drug Transfer Devices Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
4.4 Regulatory Overview
4.5 Value Chain Analysis
5. Asia Pacific Closed System Drug Transfer Devices Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Adoption of Chemotherapy
5.1.2 Increasing Adoption of Closed System Drug Transfer Devices
5.2 Market Restraints
5.2.1 Lack of Regulatory Guidelines Regarding Health Workers’ Safety in Emerging Countries
5.3 Market Opportunities
5.3.1 Rising Number of Chemotherapeutic Drug Approvals
5.4 Future Trends
5.4.1 Technological Advancement in Handling of Hazardous Drugs
5.5 Impact analysis
6. Closed System Drug Transfer Devices Market – Asia Pacific Analysis
6.1 Asia Pacific Closed System Drug Transfer Devices Market Revenue Forecasts and Analysis
7. Asia Pacific Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 – By Closing Mechanism
7.1 Overview
7.2 Asia Pacific Closed System Drug Transfer Devices Market, By Closing Mechanism 2019 & 2027 (%)
7.2.1 Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Closing Mechanism (US$ Mn)
7.3 Push-to-Turn Systems
7.3.1 Overview
7.3.2 Asia Pacific Push-to-Turn Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Colour-to-Colour Alignment System
7.4.1 Overview
7.4.2 Asia Pacific Colour-to-Colour Alignment System Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Luer-Lock Systems
7.5.1 Overview
7.5.2 Asia Pacific Luer-Lock Systems Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Click-to-Lock Systems
7.6.1 Overview
7.6.2 Asia Pacific Click-to-Lock Systems Market Revenue and Forecast to 2027 (US$ Mn)
8. Asia Pacific Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 – By Type
8.1 Overview
8.2 Asia Pacific Closed System Drug Transfer Devices Market, By Type 2019 & 2027 (%)
8.2.1 Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Type (US$ Mn)
8.3 Membrane-to-Membrane Systems
8.3.1 Overview
8.3.2 Asia Pacific Membrane-to-Membrane Systems Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Needleless Systems
8.4.1 Overview
8.4.2 Asia Pacific Needleless Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 – By Technology
9.1 Overview
9.2 Asia Pacific Closed System Drug Transfer Devices Market, By Technology 2019 & 2027 (%)
9.2.1 Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
9.3 Diaphragm-Based Devices
9.3.1 Overview
9.3.2 Asia Pacific Diaphragm-Based Devices Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Compartmentalized Devices
9.4.1 Overview
9.4.2 Asia Pacific Compartmentalized Devices Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Air Cleaning/Filtration Devices
9.5.1 Overview
9.5.2 Asia Pacific Air Cleaning/Filtration Devices Market Revenue and Forecast to 2027 (US$ Mn)
10. Asia Pacific Closed System Drug Transfer Devices Market Analysis and Forecasts To 2027 – By Component
10.1 Overview
10.2 Asia Pacific Closed System Drug Transfer Devices Market, By Component 2019 & 2027 (%)
10.2.1 Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By Component (US$ Mn)
10.3 Vial Access Devices
10.3.1 Overview
10.3.2 Asia Pacific Vial Access Devices Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Syringe Safety Devices
10.4.1 Overview
10.4.2 Asia Pacific Syringe Safety Devices Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Bag/Line Access Devices
10.5.1 Overview
10.5.2 Asia Pacific Bag/Line Access Devices Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Accessories
10.6.1 Overview
10.6.2 Asia Pacific Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
11. Asia Pacific Closed System Drug Transfer Devices Market Analysis – By End-User
11.1 Overview
11.2 Asia Pacific Closed System Drug Transfer Devices Market, By End-User 2019-2027 (%)
11.2.1 Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
11.3 Hospitals and Clinics
11.3.1 Overview
11.3.2 Asia Pacific Hospitals and Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
11.4 Oncology Centers
11.4.1 Overview
11.4.2 Asia Pacific Oncology Centers Market Revenue and Forecasts to 2027 (US$ Mn)
11.5 Others
11.5.1 Overview
11.5.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
12. Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027 – Geographical Analysis
12.1 Asia Pacific: Closed System Drug Transfer Devices Market
12.1.1 Overview
12.1.2 Asia-Pacific: Closed System Drug Transfer Devices Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
12.1.4 Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
12.1.5 Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.6 Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
12.1.7 Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
12.1.8 Asia-Pacific: Closed System Drug Transfer Devices Market, by Country, 2019 & 2027 (%)
12.1.1 China: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.1.1 China: Closed System Drug Transfer Device (CSTD) Market – Revenue and Forecast to 2027 (USD Million)
12.1.2 China Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
12.1.3 China Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
12.1.4 China Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.5 China Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
12.1.6 China Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
12.1.7 Japan: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.7.1 Japan: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.8 Japan Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
12.1.9 Japan Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
12.1.10 Japan Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.11 Japan Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
12.1.12 Japan Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
12.1.13 India: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.13.1 India: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.14 India Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
12.1.15 India Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
12.1.16 India Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.17 India Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
12.1.18 India Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
12.1.19 South Korea: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.19.1 South Korea: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.20 South Korea Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
12.1.21 South Korea Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
12.1.22 South Korea Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.23 South Korea Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
12.1.24 South Korea Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
12.1.25 Australia: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.25.1 Australia: Closed System Drug Transfer Devices Market – Revenue and Forecast to 2027 (USD Million)
12.1.26 Australia Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
12.1.27 Australia Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
12.1.28 Australia Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
12.1.29 Australia Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
12.1.30 Australia Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on Asia Pacific Closed system drug transfer devices Market
13.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Caragen Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BD
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 B. Braun Medical Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 ICU MEDICAL INC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Closing Mechanism (US$ Mn)
Table 2. Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 3. Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 4. Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By Component (US$ Mn)
Table 5. Asia Pacific Closed System Drug Transfer Devices Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 6. Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 7. Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 10. Asia Pacific Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 11. China Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 12. China Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 13. China Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. China Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 15. China Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 16. Japan Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 17. Japan Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Japan Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 19. Japan Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 20. Japan Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 21. India Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 22. India Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. India Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 24. India Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 25. India Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 26. South Korea Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 27. South Korea Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. South Korea Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 31. Australia Closed System Drug Transfer Device (CSTD) Market, by Closing Mechanism – Revenue and Forecast to 2027 (USD Million)
Table 32. Australia Closed System Drug Transfer Device (CSTD) Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Australia Closed System Drug Transfer Device (CSTD) Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 34. Australia Closed System Drug Transfer Device (CSTD) Market, by Component – Revenue and Forecast to 2027 (USD Million)
Table 35. Australia Closed System Drug Transfer Device (CSTD) Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 36. Glossary of Terms, Closed System Drug Transfer Devices Market
LIST OF FIGURES
Figure 1. Closed System Drug Transfer Devices Market Segmentation
Figure 2. Asia Pacific Closed System Drug Transfer Devices Market Overview
Figure 3. Push-to-Turn Systems Closing Mechanism Segment Held Largest Share of Closed System Drug Transfer Devices Market
Figure 4. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Closed system drug transfer devices Market - Leading Country Markets (US$ Mn)
Figure 6. Closed System Drug Transfer Devices Market - Asia Pacific PEST Analysis
Figure 7. Closed System Drug Transfer Devices Market – Value Chain Analysis
Figure 8. Closed System Drug Transfer Devices Market Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific Closed System Drug Transfer Devices Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. Asia Pacific Closed System Drug Transfer Devices Market, By Closing Mechanism 2019 & 2027 (%)
Figure 11. Asia Pacific Push-to-Turn Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Luer-Lock Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Click-to-Lock Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Closed System Drug Transfer Devices Market, By Type 2019 & 2027 (%)
Figure 16. Asia Pacific Membrane-to-Membrane Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Needleless Systems Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Closed System Drug Transfer Devices Market, By Technology 2019 & 2027 (%)
Figure 19. Asia Pacific Diaphragm-Based Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Compartmentalized Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Air Cleaning/Filtration Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Closed System Drug Transfer Devices Market, By Component 2019 & 2027 (%)
Figure 23. Asia Pacific Vial Access Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Asia Pacific Syringe Safety Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Asia Pacific Bag/Line Access Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Asia Pacific Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Asia Pacific Closed System Drug Transfer Devices Market, by End-User 2019 & 2027 (%)
Figure 28. Asia Pacific Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Asia Pacific Oncology Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Asia-Pacific: Closed System Drug Transfer Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. Asia Pacific Closed System Drug Transfer Device (CSTD) Market Revenue and Forecast to 2027 (USD Million)
Figure 33. Asia-Pacific: Closed System Drug Transfer Devices Market, by Country, 2019 & 2027 (%)
Figure 34. China: Closed System Drug Transfer Device (CSTD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Japan: Closed System Drug Transfer Device (CSTD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. India: Closed System Drug Transfer Device (CSTD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. South Korea: Closed System Drug Transfer Device (CSTD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Australia: Closed System Drug Transfer Device (CSTD) Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
The List of Companies - Asia Pacific Closed Systems Drug Transfer Devices Market
- JMS CO., LTD
- Caragen Ltd
- BD
- B. Braun Medical Inc
- ICU MEDICAL INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Closed Systems Drug Transfer Devices Market
Oct 2020
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography